Home Zacks Investment Research Lowers Discovery Laboratories, Inc. (DSCO) to Sell
 

Keywords :   


Zacks Investment Research Lowers Discovery Laboratories, Inc. (DSCO) to Sell

2015-12-29 06:13:10| Biotech - Topix.net

According to Zacks, "Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals.

Tags: research sell investment discovery

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Public Advisory Number 19A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07'Floodgates open' for legal action against water firms
03.07Atlantic Tropical Weather Outlook
03.07Eastern North Pacific Tropical Weather Outlook
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
More »